PHARMACYTE BIOTECH, INC. Notes Payable
PHARMACYTE BIOTECH, INC. (PMCB) had Notes Payable of $20.00 thousand as of 2014-01-31, per its 10-Q filed 2014-03-17.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:NotesPayable · last filed 2014-03-17
- 2014-01-31: Notes Payable $20.00K.
- 2013-10-31: Notes Payable $20.00K.
- 2013-07-31: Notes Payable $20.00K.
| Period end | Notes Payable |
|---|---|
| 2014-01-31 | $20.00K 10-Q · filed 2014-03-17 |
| 2013-10-31 | $20.00K 10-Q · filed 2013-12-16 |
| 2013-07-31 | $20.00K 10-Q · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |